Appendix B
Anatomical Therapeutic Chemical (ATC) codes used to identify cardiovascular-related medications
Archived Content
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.
Medication | ATC code | ATC description | Excluding |
---|---|---|---|
Anti-hypertensives | C02 C03 C07 C08 C09 |
Miscellaneous anti-hypertensives Thiazide diurectics Beta-blockers Calcium channel antagonists Agents acting on the Renin-Angiotensin system |
C02KX01 C03BA08, C03CA01 C07AA07, C07AA12, C07AG02 |
Lipid modifiers (statins) | C10AA C10AB C10AC C10AD C10AX C10BA C10BX |
HMG COA reductase inhibitors Fibrates Bile acid sequestrants Nicotinic acid and derivatives Other lipid modifying agents HMG CoA reductase inhibitors in combination with other lipid-modifying agents HMG CoA reductase inhibitors, other combinations |
|
Anti-thrombotic agents (anti-coagulants) | B01AA B01AB B01AE B01AF |
Vitamin K antagonists Heparin group Direct thrombin inhibitors Direct factor Xa inhibitors |
|
Anti-platelets | B01AC | Platelet aggregation inhibitors excluding heparin | |
Note: Selection of medications uses codes based on: Wilkins K, Gee M, Campbell N. The difference in hypertension control between older women and men. Health Reports 2012, 23(4). Available at: http://www.statcan.gc.ca/pub/82-003-x/2012004/article/11721-eng.pdf Source: World Health Organization. |
Report a problem on this page
Is something not working? Is there information outdated? Can't find what you're looking for?
Please contact us and let us know how we can help you.
- Date modified: